AstraZeneca R&D executive Morrison to lead cancer firm Syndax
 

AstraZeneca R&D executive Morrison to lead cancer firm Syndax
LONDON, June 15 (Reuters) - AstraZeneca's outgoing chief medical ******r and head of global late-stage drug development Briggs Morrison, whose departure from the British drugmaker was an**unced last week, is to head U.S. cancer firm Syndax Pharmaceuticals.http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1


http://da.feedsportal.com/r/23104951...21/rc/1/rc.img
http://da.feedsportal.com/r/23104951...21/rc/2/rc.img
http://da.feedsportal.com/r/23104951...21/rc/3/rc.img

http://da.feedsportal.com/r/23104951...2/sc/21/a2.img
http://adchoice.feedsportal.com/r/23.../sc/21/ach.imghttp://pi.feedsportal.com/r/23104951.../sc/21/a2t.imghttp://pi2.feedsportal.com/r/2310495...sc/21/a2t2.imghttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...s4:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...s4:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/6CX7TaSQ7oQ